AEGiS-11IAC: Beta-chemokines inhibit HIV-1 entry into CD4+ cells via the C-C CKR-5 co-receptor.

11th International AIDS Conference


Vancouver, British Columbia — July 7-12, 1996


Print this Article


Beta-chemokines inhibit HIV-1 entry into CD4+ cells via the C-C CKR-5 co-receptor.

Int Conf AIDS 1996 Jul 7-12; 11:37 (abstract no. Mo.A.275)
Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayana C, Maddon PJ, Koup RA, Moore JP, Paxton WA; The Aaron Diamond AIDS Research Center, New York, NY. Fax: (212) 725-1126.


The beta-chemokines MIP-1alpha, MIP-1beta and rantes inhibit infection of CD4+ T-cells by primary, NSI HIV-1 strains at the virus entry stage, and also block env-mediated cell-cell membrane fusion. CD4+ T-cells from some HIV-1 exposed-uninfected individuals cannot fuse with NSI HIV-1 strains and secrete high levels of beta-chemokines. Expression of the beta-chemokine receptor C-C CKR-5 in CD4+, non-permissive human and non-human cells renders them infectable by NSI strains, and also allows env-mediated membrane fusion. C-C CKR-5 is a second receptor for NSI primary viruses.
Keywords: AEGIS, Antigens, CD4, HIV-1, Chemokines, CC, RANTES, Macrophage Inflammatory Protein-1, Membrane Fusion, Cell Fusion, T-Lymphocytes, Human, ICA11KWDaegis,antigens,cd4,hiv-1,chemokines,cc,rantes,macrophageinflammatoryprotein-1,membranefusion,cellfusion,t-lymphocytes,human,ica11

960707
MoA275

Copyright © 1996 - International AIDS Society (IAS). Reproduction of this abstract (other than one copy for personal reference) must be cleared through the IAS.